Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Global HealthBOM:543654 -0.04%97 Gross Margin % is 77.43% as of Jun. 2026, which is 1% above its 10-year median of 76.57. GuruFocus rates BOM:543654 with a GF Score™ of 97/100 and a GF Value™ of ₹1,562.98 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 634 Healthcare Providers & Services companies, Global Health ranks better than 84.86% on this metric.
The historical rank and industry rank for Global Health's Gross Margin % or its related term are showing as below:
BOM:543654'
s Gross Margin % Range Over the Past 10 Years
Min: 74.95 Med: 76.57 Max: 78.06
Current: 77.54
During the past 7 years, the highestGross Margin % of Global Health was 78.06%. The lowest was 74.95%. And the median was 76.57%.
BOM:543654's Gross Margin % is ranked better than 84.86% of 634
companies
in the Healthcare Providers & Services industry
Industry Median: 40.245
vs BOM:543654: 77.54
Global Health had a gross margin of 77.43% for the quarter that ended in Jun. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Global Health was 0.30% per year.
Global Health (BOM:543654) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Global Health had a gross margin of 77.43% for the quarter that ended in Jun. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Global Health Gross Margin % Related Terms
Global Health Gross Margin % Historical Data
* Premium members only.
The historical data trend for Global Health's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:543654 vs HCA, THC, DVA: Gross Margin % Comparison
For the Medical Care Facilities subindustry, Global Health's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Global Health Gross Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Global Health's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Global Health's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Global Health (BOM:543654) has a Gross Margin % of 77.43% as of Jun. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Global Health and its competitors. This is near median its historical median of 76.57. Over the past decade, Global Health's Gross Margin % has ranged from 74.95 to 78.06. According to the industry distribution chart, Global Health ranks #96 out of 634 companies in the Healthcare Providers & Services industry, placing it in the top 15.1%.
Is Global Health's Gross Margin % too high?
Global Health's current Gross Margin % of 77.43% is near median its 10-year median of 76.57. Over the past 10 years, this metric has ranged from a low of 74.95 to a high of 78.06. The Healthcare Providers & Services industry median Gross Margin % is 40.25. Global Health's value of 77.43% is 92.4% above this industry median. Based on the distribution chart, Global Health ranks #96 out of 634 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Global Health has a GF Score™ of 97/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Global Health's Gross Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Global Health ranks #96 out of 634 companies for Gross Margin %. This places Global Health in the top 15% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 40.25. Global Health's value of 77.43% is 92.4% above this benchmark. Historically, Global Health's own Gross Margin % has ranged from 74.95 to 78.06 over the past decade. While the company's 10-year median is 76.57 vs. the industry median of 40.25, Global Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Healthcare Providers & Services company?
The median Gross Margin % among Healthcare Providers & Services companies is 40.25, based on 634 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Global Health's current Gross Margin % of 77.43% is 92.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Global Health and its competitors. For the Healthcare Providers & Services industry, the median Gross Margin % is 40.25 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Global Health's current Gross Margin % is 77.43%, which is near median its own 10-year median of 76.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Global Health stock overvalued right now?
Based on GuruFocus' analysis, Global Health (BOM:543654) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹1,562.98, compared to a current price of ₹1,404.70 — trading 10.1% below its estimated fair value. The current Gross Margin % is 77.43%, which is near median its 10-year median of 76.57 and 92.4% above the Healthcare Providers & Services industry median of 40.25. Global Health's overall GF Score™ is 97/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Global Health (BOM:543654), the current Gross Margin % is 77.43% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Global Health (BOM:543654) Overvalued in 2026?
Based on GuruFocus' analysis, Global Health stock appears to be undervalued.
The current stock price of ₹1,404.70 is trading 10.1% below its estimated GF Value™ of ₹1,562.98.
GuruFocus considers Global Health to be Modestly Undervalued.
Key valuation signals for BOM:543654:
Gross Margin %: 77.43% (near median its 10-year median of 76.57)
GF Value™: ₹1,562.98 vs. price of ₹1,404.70 (10.1% below fair value)
Industry Position: 92.4% above the Healthcare Providers & Services median (#96 of 634)
No single metric tells the full story. See the BOM:543654 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Global Health Ltd operates as a private multi-specialty tertiary care provider operating in the North and East regions of India, with key specialties of cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplant, and kidney and urology. Under the Medanta brand, it has a network of hospitals in operation (Gurugram, Indore, Ranchi, and Lucknow), a hospital that is under construction with an operational outpatient facility (Patna), and a hospital (Noida) planned for development. The Group operates Healthcare services as a single business segment in India, constituting a single geographical segment.
97GF Score
Get the complete analysis for BOM:543654
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543654 has been successfully added to your 
